/NGRC

NGRC Stock - National Graphite Corp.

Q: What is the analyst price target for NGRC?

Analyst price target information is not currently available for NGRC.

Q: What is NGRC's market cap?

Market capitalization information is not currently available for NGRC.

Financial Services|Shell Companies|OTC

$0.02+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.02

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NGRC

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2014

FY2022

FY2023

FY2025

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-2.51

52W High$0.08

52W Low$0.02

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2025	FY2023	FY2022	FY2014
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-46,035	$-46,035	$-54,774	$-25,825	$-2,167,576
Net Income	$-53,235	$-53,235	$-61,974	$-33,025	$-1,968,289
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$0.00	$0.00	$-0.00	$-0.00	$-0.00

Company Overview

National Graphite Corp., through its subsidiary, Biotech Development Corp., operates as a biopharmaceutical risk/cost-sharing company. The company collaborates with clinical stage companies that develop new biological entities or new therapeutically platforms for the treatment of various diseases, rare diseases, and diseases with unmet needs. It is developing a drug candidate called ELAFIN, which is a human identic protein for the treatment of postoperative inflammatory complications. National Graphite Corp. has a collaboration agreement with Proteo Inc. for developing ELAFIN. The company was formerly known as Lucky Boy Silver Corporation and changed its name to National Graphite Corp. in May 2012. National Graphite Corp. was founded in 2006 and is based in Duesseldorf, Germany.

Frequently Asked Questions about NGRC

What is NGRC's current stock price?

National Graphite Corp. (NGRC) is currently trading at $0.02 per share. The stock has moved +0.00% today.

What is the analyst price target for NGRC?

No analyst price targets are currently available for this stock.

What sector is National Graphite Corp. in?

National Graphite Corp. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the OTC exchange.

What is NGRC's market cap?

National Graphite Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does NGRC pay dividends?

No, National Graphite Corp. does not currently pay a dividend to shareholders.